Dietary omega-3 fatty acids attenuate myocardial arrhythmogenic factors and propensity of the heart to lethal arrhythmias in a rodent model of human essential hypertension

Journal of Hypertension

Volumn 31, Issue 9, 2013, Pages 1876-1885

  Radosinska, Jana ^a,b   Bacova, Barbara ^a   Knezl, Vladimir ^a   Benova, Tamara ^a   Zurmanova, Jitka ^c   Soukup, Tomas ^d   Arnostova, Petra ^c   Slezak, Jan ^a   Goncalvesova, Eva ^e   Tribulova, Narcisa ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b Physics and Informatics   (Slovakia)

^c CHARLES UNIVERSITY   (Czech Republic)

^d INSTITUTE OF MATHEMATICS   (Czech Republic)

^e National Cardiovascular Institute   (Slovakia)

Author keywords

Hypertension; Myocardial connexin 43; Myosin heavy chain; Omega 3 polyunsaturated fatty acids; Protein kinase C; Sinus rhythm restoration; Ventricular fibrillation

Indexed keywords

CONNEXIN 43; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; ISOPROTEIN; MESSENGER RNA; MYOSIN HEAVY CHAIN; OMEGA 3 FATTY ACID; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; GAP JUNCTION; HEART PERFUSION; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; INTERNALIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; RODENT MODEL; SINUS RHYTHM; SPONTANEOUSLY HYPERTENSIVE RAT; TISSUE PREPARATION; TREATMENT DURATION;

ANIMALS; ARRHYTHMIAS, CARDIAC; BLOOD PRESSURE; CONNEXIN 43; DIET; DISEASE MODELS, ANIMAL; FATTY ACIDS, OMEGA-3; GAP JUNCTIONS; GENE EXPRESSION REGULATION; HYPERTENSION; MALE; MYOCARDIUM; MYOSIN HEAVY CHAINS; PROTEIN ISOFORMS; PROTEIN KINASE C; RATS; RATS, INBRED SHR; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 84884203573     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328362215d     Document Type: Article

References (49)

1. Loirand G, Pacaud P. The role of Rho protein signaling in hypertension. Nat Rev Cardiol 2010; 7:637-647.
2. Diamond JA, Phillips RA. Hypertensive heart disease. Hypertens Res 2005; 28:191-202.
3. Mancia G, Scopelliti F, Grassi G. Hypertension and the heart. Semin Cardiothorac Vasc Anesth 2006; 10:198-202.
4. Zanchetti A. Is hypertension a fatal disease today? Proceedings of a satellite symposium held during the 21st European Meeting on Hypertension and Cardiovascular Prevention Milan (Italy), Foreword; 17-20 June 2011. J Hypertens 2011; 29:1.
5. Simko F, Pechanova O, Pelouch V., Krajcirovicova K, Mullerova M, Bednarova K., et al. Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats. J Hypertens Suppl 2009; 27:5-10.
6. Simko F, Pechanova O. Remodelling of the heart and vessels in experimental hypertension: advances in protection. J Hypertens 2010; 28:1-6.
7. Hill JA. Electrical remodeling in cardiac hypertrophy. Trends Cardiovasc Med 2003; 13:316-322.
8. Teunissen BEJ, Jongsma HJ, Bierhuizen MFA. Regulation of myocardial connexins during hypertrophic remodelling. Eur Heart J 2004; 25: 1979-1989.
9. Tribulova N, Okruhlicova L, Imanaga I., Hirosawa N, Ogawa K, Weismann P. Factors involved in the susceptibility of spontaneously hypertensive rats to low K+-induced arrhythmias. Gen Physiol Biophys 2003; 22:369-382.
10. Mitasikova M, Smidova S, Macsaliova A., Knezl V, Dlugosova K, Okruhlicova L., et al. Aged male and female spontaneously hypertensive rats benefit from n-3 polyunsaturated fatty acids supplementation. Physiol Res 2008; 57 (SUPPL. 2):S39-S48.
11. Fischer R, Dechend R, Qadri F., Markovic M, Feldt S, Herse F., et al. Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension. Hypertension 2008; 51:540-546.
12. Kostin S, Dammer S, Hein S. Connexin 43 expression and distribution in compensated and decompensated cardiac hypetrophy in patients with aortic stenosis. Cardiovas Res 2004; 62:426-436.
13. Peters NS, Coromilas J, Severs N.J., Wit AL. Disturbed connexin 43 gap junction distribution correlates with location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation 1997; 95:988-996.
14. Severs NJ. Gap junction remodelling and cardiac arrhythmogenesis: cause or coincidence? J Cell Mol Med 2001; 5:355-366.
15. Tribulova N, Knezl V, Okruhlicova L., Slezak J. Myocardial gap junctions: targets for novel approaches in the prevention of life-threatening cardiac arrhythmias. Physiol Res 2008; 57:1-13.
16. Tribulova N, Okruhlicova L, Novakova S., Pancza D, Bernatova I, Pechanova O., et al. Hypertension-related intermyocyte junction remodelling is associated with a higher incidence of low-K(+)-induced lethal arrhythmias in isolated rat heart. Exp Physiol 2002; 87:195-205.
17. Dhein S. Gap junctional channels in cardiovascular system: pharmacological and physiological modulation. Trends Pharmacol Sci 1998; 19:229-241.
18. Lin H, Mitasikova M, Dlugosova K., Okruhlicova L, Imanaga I, Ogawa K., et al Thyroid hormones suppress epsilon-PKC signaling, down-regulate connexin-43 and increase lethal arrhythmia susceptibility in nondiabetic and diabetic rat hearts. J Physiol Pharmacol 2008; 59:271-285.
19. Tribulova N, Seki S, Radosinska J., Kaplan P, Babusikova E, Knezl V., Mochizuki S. Myocardial Ca2+ handling and cell-to-cell coupling, key factors in prevention of sudden cardiac death. Can J Physiol Pharmacol 2009; 87:1120-1129.
20. Jeyaraman MM, Srisakuldee W, Nickel B.E., Kardami E. Connexin43 phosphorylation and cytoprotection in the heart. Biochim Biophys Acta 2012; 1818:2009-2013.
21. Rybin VO, Guo J, Sabri A., Elouardighi H, Schaefer E, Steinberg SF. Stimulus-specific differences in protein kinase C delta localization and activation mechanisms in cardiomyocytes. J Biol Chem 2004; 279:19350-19361.
22. Brooks WW, Bing OH, Blaustein A.S., Allen PD. Comparison of contractile state and myosin isozymes of rat right and left ventricular myocardium. J Mol Cell Cardiol 1987; 19:433-440.
23. Manoach M, Tribulova N, Vogelezang D., Thomas S, Podzuweit T. Transient ventricular fibrillation and myosin heavy chain isoform profile. J Cell Mol Med 2007; 11:171-174.
24. Anderson KP. Lipid-lowering therapy for prevention of ventricular tachyarrhythmias. J Am Coll Cardiol 2003; 42:88-92.
25. Singh BN. Augmenting maintenance of sinus rhythm in the control of atrial fibrillation by antiarrhythmic drug combinations. J Cardiovasc Pharmacol Ther 2010; 15:31-35.
26. Bacova B, Radosinska J, Knezl V., Kolenova L, Weismann P, Navarova J., et al. Omega-3 fatty acids and atorvastatin suppress ventricular fibrillation inducibility in hypertrigly-ceridemic rat hearts: implication of intracellular coupling protein, connexin-43. J Physiol Pharmacol 2010; 61:717-723.
27. London B, Albert C, Anderson M.E., Giles WR, Van Wagoner DR, Balk E, et al. Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research - a report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop. Circulation 2007; 116:320-335.
28. Richardson ES, Iaizzo PA, Xiao YF. Electrophysiological mechanisms of the antiarrhythmic effects of omega-3 fatty acids. J Cardiovasc Trans Res 2011; 4:42-52.
29. Rupp H. Omacor (prescription omega-3-acid ethyl esters 90): from severe rhythm disorders to hypertriglyceridemia. Adv Ther 2009; 26:675-690.
30. Reiffel JA, McDonald A. Antiarrhytmic effects of omega-3 fatty acids. Am J Cardiol 2006; 98:50-60.
31. Nair SS, Leitch JW, Falconer J, Garg ML. Prevention of cardiac arrythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action. J Nutr 1997; 127:383-393.
32. Radosinska J, Bacova B, Bernatova I., Navarova J, Zhukovska A, Shysh A., et al. Myocardial NOS activity and connexin-43 expression in untreated and omega-3 fatty acids-treated spontaneously hypertensive and hereditary hypertriglyceridemic rats. Mol Cell Biochem 2011; 347:163-173.
33. Bing OH, Brooks WW, Robinson K.G., Slawsky MT, Hayes JA, Litwin SE, et al. The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J Mol Cell Cardiol 1995; 27:383-396.
34. Bacova B, Radosinska J, Viczenczova C., Knezl V, Dosenko V, Benova T., et al. Up-regulation of myocardial connexin-43 in spontaneously hypertensive rats fed red palm oil is most likely implicated in its antiarrhythmic effects. Can J Physiol Pharmacol 2012; 90:1235-1245.
35. Arnostova P, Jedelsky PL, Soukup T, Zurmanova J. Electrophoretic mobility of cardiac myosin heavy chain isoforms revisited: application of MALDI TOF/TOF analysis. J Biomed Biotechnol 2011; 2011:634253.
36. Cooklin M, Wallis WR, Sheridan D.J., Fry CH. Changes in cell-to-cell electrical coupling associated with left ventricular hypertrophy. Circ Res 1997; 80:765-771.
37. Duthe F, Dupont E, Verrecchia F., Plaisance I, Severs NJ, Sarrouilhe D, Hervé JC. Dephosphorylation agents depress gap junctional communication between rat cardiac cells without modifying the connexin43 phosphorylation degree. Gen Physiol Biophys 2000; 19:441-449.
38. Imanaga I, Hirosawa N, Lin H., Sakamoto Y, Matsumura T, Mayama K. Phosphorylation of connexin43 and regulation of cardiac gap junction. In: DeMello WC, Janse M, editors. Heart cell coupling and impulse propagation in health and disease. Boston, Dordrecht, London: Kluwer Academic Publishers; 2002. pp. 185-205.
39. Beardslee MA, Lerner DL, Tadros P.N., Laing JG, Beyer EC, Yamada KA, et al. Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ Res 2000; 87:656-662.
40. Tribulova N, Manoach M, Varon D., Okruhlicova L, Zinman T, Shainberg A. Dispersion of cell-to-cell uncoupling precedes low K+-induced ventricular fibrillation. Physiol Res 2001; 50:247-259.
41. Gutstein DE, Danik SB, Lewitton S, France D., Liu F, Chen FL, et al. Focal gap junction uncoupling and spontaneous ventricular ectopy. Am J Physiol Heart Circ Physiol 2005; 289:H1091-H1098.
42. Peters NS. New insight into myocardial arrhythmogenesis: distribution of gap-junctional coupling in normal, ischemic and hypertrophied human hearts. Clin Sci (Lond) 1996; 90:447-452.
43. Radosinska J, Bacova B, Dosenko V., Lin H, Imanaga I, Tribulova N. Spontaneously diabetic rats in prehypertensive stage benefit from omega-3 fatty acids supplementation. J Hypertens 2010; 28:292-293.
44. Al-Gubory KH. Mitochondria: omega-3 in the route of mitochondrial reactive oxygen species. Int J Biochem Cell Biol 2012.
45. Smyth JW, Hong TT, Gao D, Vogan J.M., Jensen BC, Fong TS, et al Limited forward trafficking of connexin 43 reduces cell-cell coupling in stressed human and mouse myocardium. J Clin Invest 2010; 120:266-279.
46. Lin H, Ogawa K, Imanaga I., Tribulova N. Alterations of connexin 43 in the diabetic rat heart. Adv Cardiol 2006; 42:243-254.
47. Dhein S, Michaelis B, Mohr FW. Antiarrhythmic and electrophysiological effect of long-chain ω-3 polyunsaturated fatty acids. Arch Pharmacol 2005; 371:202-211.
48. Hamplova B, Novak F, Kolar F., Novakova O. Transient upregulation of protein kinase C in pressure-overloaded neonatal rat myocardium. Physiol Res 2010; 59:25-33.
49. Steinberg SF. Distinctive activation mechanisms and functions for protein kinase Cdelta. Biochem J 2004; 384:449-459.